Skip to content
Psilocybin Technology
Menu
  • Home
  • Contact us about Psilocybin Science and Technology

Category: Unmet Need

Business / Patents / Psilocybin / Psilocybin Derivatives / Unmet Need

MagicMed – The First Psychedelic Patent Troll?

Is MagicMed Industries Inc. the first patent troll to enter the psychedelic space? Or has MagicMed come up with a brilliant plan that will benefit the entire psychedelics industry by …

Psilocybin Chemistry / Psilocybin Science / State of the Art / Unmet Need

American Chemical Society Meeting – Only One Talk about Psychedelics?

The upcoming 2019 American Chemical Society (“ACS”) Fall Meeting and Exposition in San Diego features two presentations pertaining to psychedelic chemistry: (1) a talk by Dr. David Manke and Dr. …

Microdosing / Molecules vs. Mushrooms / Mushrooms / State of the Art / Treatment / Unmet Need

Review of the State of the Art for Microdosing Psychedelics

As of July 2019 the state of the art for microdosing psychedelics is best described as a collection anecdotal reports from people taking unknown amounts of unknown drugs at wildly …

Cognitive Enhancement / Mass / Microdosing / Molecules vs. Mushrooms / Mushrooms / Psilocybin / Psilocybin Chemistry / State of the Art / Unmet Need

Science Trends Illustrates Problems Defining and Describing Microdosing

Microdosing Described by Alex Bolano of Science Trends On October 29th, Science Trends published an article by Alex Bolano about how microdosing psychedelic mushrooms could stimulate creative thought. At a …

Molecules vs. Mushrooms / Psilocybin / Psilocybin Chemistry / Psilocybin Derivatives / Research / State of the Art / Unmet Need

Magic Mushrooms vs Cannabis – Entourage Effect

Entourage Effect – Synergistic Combinations of Active Ingredients Magic mushrooms contain multiple active ingredients, collectively called “psilocybin derivatives.” These molecules work together to create an “entourage” of psychoactive (and non-psychoactive) effects …

Microdosing / Psilocybin / Research / State of the Art / Treatment / Unmet Need

Microdosing – Petranker and Anderson on State of the Art

Microdosing Study by Petranker and Anderson Newsweek magazine just published an article about microdosing psychedelics (e.g., psilocybin mushrooms, LSD, etc.). The article reported a “new study” conducted by a “team …

Depression / Psilocybin / Research / Treatment / Unmet Need

COMPASS Pathways – Access to Synthetic Psilocybin

COMPASS Pathways Targeting “Patient Access” to Synthetic Psilocybin COMPASS Pathways is a life sciences company, founded in 2016, to “accelerate patient access to evidence-based innovation in mental health.” According to their …

Anxiety / Cognitive Enhancement / Depression / Microdosing / Mushrooms / Psilocybin / Psilocybin Chemistry / Research / State of the Art / Treatment / Unmet Need

Microdosing Psilocybin with Psilocybin Mushrooms

Microdosing Psilocybin with Psilocybin Mushrooms What does “microdosing” psilocybin mean? What is the state of the art for microdosing ? How can we improve the state of the art? What …

Molecules vs. Mushrooms / Mushrooms / Psilocybin / Psilocybin Chemistry / Psilocybin Derivatives / Research / State of the Art / Unmet Need / Wood Lover Paralysis

Question: Different Effects from Different Magic Mushrooms?

Different Effects from Different Mushrooms? Anecdotal evidence suggests that different batches of magic mushrooms lead to different effects for the users consuming them.  For example, some discussions refer to various …

Microdosing / Psilocybin / State of the Art / Unmet Need

Microdosing Formulations are a Game Changer

Microdosing Formulations Eliminate the Need for Gambling with Your Mind Recently, we published several articles about the growing popularity of microdosing psilocybin.  In sum, the practice of microdosing could be easily …

Posts navigation

Older posts

Recent Posts

  • Nova Mentis Launches Entourage Effect Research
  • Graham Pechenik and Noah Potter discuss Psychedelic Patents
  • MindMed – Two Steps Closer to Next Generation Magic Mushroom Formulations
  • COMPASS Pathways’ $100+ Million Crystalline Form Patent
  • MagicMed – The First Psychedelic Patent Troll?

Recent Comments

  • Psilocybin Expert on Taking Pure Psilocybin is Different from Eating Magic Mushrooms
  • jim on Cannabis and Magic Mushrooms – A Near Perfect Analogy
  • jeff on China Enters Magic Mushroom Industry – Wuhan, MJMedTech, and M2BIO
  • jeff on Chemical & Engineering News Discusses Entourage Effect
  • jeff on Psilocybin Clinical Trials Approved by FDA

Archives

  • January 2021
  • November 2020
  • September 2020
  • July 2020
  • February 2020
  • January 2020
  • December 2019
  • August 2019
  • July 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • November 2017
  • October 2017

Categories

  • Aeruginascin
  • Anxiety
  • Business
  • Cognitive Enhancement
  • Decriminalization
  • Depression
  • Law
  • Legalization
  • Mass
  • Microdosing
  • Molecules vs. Mushrooms
  • Mushrooms
  • Patents
  • Psilocin
  • Psilocybin
  • Psilocybin Chemistry
  • Psilocybin Derivatives
  • Psilocybin Science
  • Research
  • State of the Art
  • Treatment
  • Uncategorized
  • Unmet Need
  • Wood Lover Paralysis

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Copyright © 2021 Psilocybin Technology – OnePress theme by FameThemes